These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25563294)

  • 1. Alternative NHEJ Pathway Components Are Therapeutic Targets in High-Risk Neuroblastoma.
    Newman EA; Lu F; Bashllari D; Wang L; Opipari AW; Castle VP
    Mol Cancer Res; 2015 Mar; 13(3):470-82. PubMed ID: 25563294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative NHEJ pathway proteins as components of MYCN oncogenic activity in human neural crest stem cell differentiation: implications for neuroblastoma initiation.
    Newman EA; Chukkapalli S; Bashllari D; Thomas TT; Van Noord RA; Lawlor ER; Hoenerhoff MJ; Opipari AW; Opipari VP
    Cell Death Dis; 2017 Dec; 8(12):3208. PubMed ID: 29238067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated Leukemias.
    Muvarak N; Kelley S; Robert C; Baer MR; Perrotti D; Gambacorti-Passerini C; Civin C; Scheibner K; Rassool FV
    Mol Cancer Res; 2015 Apr; 13(4):699-712. PubMed ID: 25828893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked contribution of alternative end-joining to chromosome-translocation-formation by stochastically induced DNA double-strand-breaks in G2-phase human cells.
    Soni A; Siemann M; Pantelias GE; Iliakis G
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():2-8. PubMed ID: 26520366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias.
    Tobin LA; Robert C; Rapoport AP; Gojo I; Baer MR; Tomkinson AE; Rassool FV
    Oncogene; 2013 Apr; 32(14):1784-93. PubMed ID: 22641215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways.
    Wang M; Wu W; Wu W; Rosidi B; Zhang L; Wang H; Iliakis G
    Nucleic Acids Res; 2006; 34(21):6170-82. PubMed ID: 17088286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness.
    Richter C; Marquardt S; Li F; Spitschak A; Murr N; Edelhäuser BAH; Iliakis G; Pützer BM; Logotheti S
    J Exp Clin Cancer Res; 2019 Jul; 38(1):292. PubMed ID: 31287003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joining.
    Soni A; Siemann M; Grabos M; Murmann T; Pantelias GE; Iliakis G
    Nucleic Acids Res; 2014 Jun; 42(10):6380-92. PubMed ID: 24748665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells.
    Schulte JH; Kuhfittig-Kulle S; Klein-Hitpass L; Schramm A; Biard DS; Pfeiffer P; Eggert A
    DNA Repair (Amst); 2008 Oct; 7(10):1757-64. PubMed ID: 18678285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of DNA double-strand break repair pathways in diffuse large B cell lymphoma.
    Gopalakrishnan V; Dahal S; Radha G; Sharma S; Raghavan SC; Choudhary B
    Mol Carcinog; 2019 Feb; 58(2):219-233. PubMed ID: 30298948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common and unique genetic interactions of the poly(ADP-ribose) polymerases PARP1 and PARP2 with DNA double-strand break repair pathways.
    Ghosh R; Roy S; Kamyab J; Danzter F; Franco S
    DNA Repair (Amst); 2016 Sep; 45():56-62. PubMed ID: 27373144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation.
    Simsek D; Brunet E; Wong SY; Katyal S; Gao Y; McKinnon PJ; Lou J; Zhang L; Li J; Rebar EJ; Gregory PD; Holmes MC; Jasin M
    PLoS Genet; 2011 Jun; 7(6):e1002080. PubMed ID: 21655080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absence of Ku but not defects in classical non-homologous end-joining is required to trigger PARP1-dependent end-joining.
    Mansour WY; Borgmann K; Petersen C; Dikomey E; Dahm-Daphi J
    DNA Repair (Amst); 2013 Dec; 12(12):1134-42. PubMed ID: 24210699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parp1-XRCC1 and the repair of DNA double strand breaks in mouse round spermatids.
    Ahmed EA; de Boer P; Philippens ME; Kal HB; de Rooij DG
    Mutat Res; 2010 Jan; 683(1-2):84-90. PubMed ID: 19887075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting abnormal DNA repair in therapy-resistant breast cancers.
    Tobin LA; Robert C; Nagaria P; Chumsri S; Twaddell W; Ioffe OB; Greco GE; Brodie AH; Tomkinson AE; Rassool FV
    Mol Cancer Res; 2012 Jan; 10(1):96-107. PubMed ID: 22112941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP1 Links CHD2-Mediated Chromatin Expansion and H3.3 Deposition to DNA Repair by Non-homologous End-Joining.
    Luijsterburg MS; de Krijger I; Wiegant WW; Shah RG; Smeenk G; de Groot AJL; Pines A; Vertegaal ACO; Jacobs JJL; Shah GM; van Attikum H
    Mol Cell; 2016 Feb; 61(4):547-562. PubMed ID: 26895424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin.
    Robert C; Nagaria PK; Pawar N; Adewuyi A; Gojo I; Meyers DJ; Cole PA; Rassool FV
    Leuk Res; 2016 Jun; 45():14-23. PubMed ID: 27064363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear PTEN interferes with binding of Ku70 at double-strand breaks through post-translational poly(ADP-ribosyl)ation.
    Guan J; Zhao Q; Mao W
    Biochim Biophys Acta; 2016 Dec; 1863(12):3106-3115. PubMed ID: 27741411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homology and enzymatic requirements of microhomology-dependent alternative end joining.
    Sharma S; Javadekar SM; Pandey M; Srivastava M; Kumari R; Raghavan SC
    Cell Death Dis; 2015 Mar; 6(3):e1697. PubMed ID: 25789972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential requirement for H2AX and 53BP1 in organismal development and genome maintenance in the absence of poly(ADP)ribosyl polymerase 1.
    Orsburn B; Escudero B; Prakash M; Gesheva S; Liu G; Huso DL; Franco S
    Mol Cell Biol; 2010 May; 30(10):2341-52. PubMed ID: 20231360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.